23andMe Holding Co.

NAS: ME

GO
/marketstate/country/us

Market open

 --Real time quotes

Feb 2, 2023, 9:47 a.m.

ME
/zigman2/quotes/222659849/composite

$

2.72

Change

+0.16 +6.25%

Volume

Volume 214,989

Real time quotes

/zigman2/quotes/222659849/composite

Previous close

$ 2.56

$ 2.72

Change

+0.16 +6.25%

Day low

Day high

$2.63

$2.74

Open

52 week low

52 week high

$2.02

$6.31

Open

Evan M. Lovell

Evan M. Lovell founded VGF Advisers (US) LLC. Presently, Mr. Lovell is Chairman for Virgin Galactic Holdings, Inc., Chief Financial Officer & Director at Virgin Group Acquisition Corp. III, Chief Investment Officer for Virgin Group, Chief Investment Officer for VO Holdings, Inc., Chief Investment Officer at Virgin Models Ltd. and Partner at VGF Advisers (US) LLC. Mr. Lovell is also Partner at Virgin Group Holdings Ltd. and Investment Partner at VGF I Ltd. and on the board of 17 other companies.

In the past Evan M. Lovell held the position of Chairman for Astrum International Corp, Director-International Development at Culligan International Co., Advisor at Vermont Center for Emerging Technologies, Chief Financial Officer & Director at VG Acquisition Corp., Director, Chief Financial & Accounting Officer at Virgin Group Acquisition Corp. II, Founding partner of VGF Advisers (UK) LLP, Founding Partner of VGF Advisers (UK) LLP, Director at Eden Springs UK Ltd. and Principal at TPG Growth LLC.

He received an undergraduate degree from the University of Vermont.

Transactions

Date Shares Transaction Value
03/10/2022 11,467   Acquisition at $4.41 per share. 50,569

Officers and Executives

Ms. Anne E. Wojcicki
President, Chief Executive Officer & Director
Mr. Joseph Selsavage
Chief Financial & Accounting Officer
Mr. Steve Lemon
Vice President-Engineering
Dr. Joyce Tung
Vice President-Research
Dr. L. Okey Onyejekwe
VP-Healthcare Operations & Medical Affairs
Dr. Joseph R. Arron
Chief Scientific Officer
Ms. Kathy L. Hibbs
Secretary & Chief Administrative Officer
Dr. Kenneth J. Hillan
Chief Therapeutics Officer
Mr. Adam Auton
Vice President-Human Genetics
Mr. David Baker
Chief Security Officer
Dr. Arnab Chowdry
Vice President-Genetic Technology
Mr. Kent Hillyer
Vice President-Customer Care
Dr. Jennifer Low
Head-Therapeutics Development
Mr. Mike Polcari
Vice President & Chief Architect
Dr. William Richards
Vice President-Drug Discovery
Dr. Monica Viziano
VP-Portfolio Strategy & Alliance Management
Mr. Paul Johnson
Chief Operating Officer-Consumer
Mr. Daniel Chu
Chief Product Officer
Mr. Evan M. Lovell
Director
Dr. Richard H. Scheller
Director
Ms. Tracy Keim
Vice President-Consumer Marketing & Brand
Dr. D. Wade Walke
Vice President-Investor Relations
Ms. Jacquie Cooke Haggarty
General Counsel & Privacy Officer
Mr. Roelof Frederik Botha
Independent Director
Mr. Patrick Shuao-Fong Chung
Independent Director
Mr. Peter J. Taylor
Independent Director
Dr. Valerie C. Montgomery Rice
Independent Director
Dr. Sandra Rae Hernández
Independent Director
Mr. Neal Mohan
Independent Director
Link to MarketWatch's Slice.